CVS Health Delivering on Commitment to Establish up to 1,000 COVID-19 Test Sites by End of May

Thursday, October 1, 2020

Building on the company’s comprehensive efforts to help slow the spread of the virus, on Friday, May 15 CVS Health will open more than 50 COVID-19 test sites at select CVS Pharmacy drive-thru locations across Arizona, Connecticut, Florida, Massachusetts and Pennsylvania. The opening of hundreds of additional test sites across the country will be announced over the next two weeks.

The new sites will utilize self-swab tests and mark the next phase of the company’s COVID-19 testing strategy, announced April 27 at the White House. CVS Health expects to have up to 1,000 locations across the country offering this service by the end of May, with the goal of processing up to 1.5 million tests per month, subject to availability of supplies and lab capacity. The company currently operates large-scale rapid test sites in coordination with five states, which can process a total of nearly 30,000 tests per week.

“While the large-scale test sites we’ve been operating since early April have proven successful, this new approach allows us to utilize our presence in communities across the country and bring testing closer to home,” said Larry J. Merlo, President and CEO, CVS Health. “Our frontline employees will continue to play a critical role in the testing process, with members of their communities directly benefitting from their dedication and selflessness.”

Self-swab tests will be available to individuals meeting Centers for Disease Control and Prevention criteria, in addition to age guidelines. Patients must register in advance at CVS.com beginning Friday, May 15 to schedule an appointment. Patients will be required to stay in their cars and directed to the pharmacy drive-thru window where they will be provided with a test kit and given instructions; a CVS Pharmacy team member will observe the self-swab process to ensure it is done properly. Tests will be sent to an independent, third-party lab for processing and the results will be available in approximately three days.

Testing will not take place inside any retail locations, and CVS Pharmacy, HealthHUB and MinuteClinic will continue to serve customers and patients.

More information on steps CVS Health has taken to address the COVID-19 pandemic, including support for health care providers and clinicians facing financial and administrative strain, is available at the company’s frequently updated COVID-19 resource center.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here